Clinical Trials List
2017-05-16 - 2019-09-30
Phase I
Terminated3
ICD-10C92
Myeloid leukemia
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Ya-Ting Hsu Division of General Internal Medicine
- Sin-Syue Li Division of General Internal Medicine
- Hui-Jen Tsai Division of General Internal Medicine
- Shang-Yin Wu Division of General Internal Medicine
- Yu-Min Yeh Division of General Internal Medicine
- Wei-Pang Chung Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Co-Principal Investigator
- Ming-Chung Kao Division of Hematology & Oncology
- Po-Nan Wang Division of Hematology & Oncology
- 高小雯 Division of Hematology & Oncology
- 洪玉馨 Division of Hematology & Oncology
- Tung-Liang Lin Division of Hematology & Oncology
- 湯崇志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Ta-Chih Liu Division of Hematology & Oncology
- Hui-Ching Wang Division of Hematology & Oncology
- 蔡郁棻 Division of Hematology & Oncology
- Hui-Hua Hsiao Division of Hematology & Oncology
- Shih-Feng Cho Division of Hematology & Oncology
- Yi-Chang Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
22 participants
-
Global
22 participants
